Allergan, a pharmaceutical company based in Dublin, Ireland, yesterday announced that the US Food and Drug Administration (FDA) has approved an expanded indication for its antibiotic combination drug Avycaz (ceftazidime and avibactam) to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by gram-negative organisms.
Preliminary indications into South Sudan's recent viral hemorrhagic fever outbreak suggest that Rift Valley fever (RVF) may be the cause, the World Health Organization (WHO) Regional Office for Africa said in its latest outbreak and health emergencies update.
A phase 3 trial shows ceftazidime-avibactam "non-inferior" to meropenem.
The Saudi Arabian Ministry of Health (MOH) today reported a new case of MERS-CoV in Bisha, the third within the last week.
A 67-year-old Saudi woman is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection. Her source of infection is listed as "primary," meaning it's unlikely she contracted the virus from another person.
Fever, crackling in the lungs, high pulse, and low blood oxygen may be predictive.
More than two thirds of adult hospital patients are on the drugs longer than needed.
Using just 1 drug instead of 2 could go a long way in curbing azithromycin use.
Influenza is finally on the decline in Australia, according to yesterday's global flu update from the World Health Organization (WHO). Influenza A, H3N2, remained the dominant circulating strain, followed by influenza B.
A review finds the biomarker cut mortality and antibiotic exposure in patients with acute respiratory infections.
The World Health Organization (WHO) today said it has received word of an attack at medical facilities in Syria that destroyed the only vaccines cold room in a district where several polio cases have been reported over the past several months.
